Location: SuZhou, China
Date:
Event description: Join us at the BIOCHINA (EBC) Conference in SuZhou, China, from March 14 to 16, 2024, as Novotech takes the stage to share valuable insights and engage in discussions around the latest advancements in clinical development. Charley Sha, Regulatory Affairs Director at Novotech, will deliver a compelling speech on "Regulatory Considerations for MRCT Development of ADC." This session aims to share important regulatory insights, providing a roadmap for navigating the complexities of ADC development within the framework of Multiregional Clinical Trials (MRCT). Following the enlightening speech, Charley Sha will actively participate in a Roundtable Discussion. This interactive session offers a unique opportunity to explore further into the Regulatory Affairs of Global Development, fostering a collaborative environment for knowledge exchange and networking. Don't miss this chance to connect with industry leaders, experts, and Novotech at the BIOCHINA (EBC) Conference 2024. Schedule a meeting to connect with a Novotech expert at BIOCHINA by simply filling the form. See you there!
Schedule a meeting with our attendees
Meet Our Team
Charley Sha
Plus experts from our China, Drug Development, and global Commercial teams.